Christopher L. Reading

2.2k total citations
74 papers, 1.8k citations indexed

About

Christopher L. Reading is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Christopher L. Reading has authored 74 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Hematology and 20 papers in Immunology. Recurrent topics in Christopher L. Reading's work include Glycosylation and Glycoproteins Research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Christopher L. Reading is often cited by papers focused on Glycosylation and Glycoproteins Research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Christopher L. Reading collaborates with scholars based in United States, Italy and Netherlands. Christopher L. Reading's co-authors include Edward E. Penhoet, James M. Frincke, Garth L. Nicolson, Clarence Ahlem, Dominick L. Auci, Sergio Giralt, Börje S. Andersson, Rakesh Mehra, Donna Przepiorka and Koen van Besien and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Christopher L. Reading

73 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher L. Reading United States	19	731	448	350	338	313	74	1.8k
Nechama Haran‐Ghera Israel	28	813 1.1×	475 1.1×	858 2.5×	594 1.8×	285 0.9×	125	2.4k
Shinichiro Takahashi Japan	26	1.5k 2.0×	574 1.3×	427 1.2×	403 1.2×	79 0.3×	112	2.6k
J Wietzerbin France	21	522 0.7×	225 0.5×	687 2.0×	360 1.1×	118 0.4×	44	1.9k
Monique Plantavid France	28	1.4k 1.9×	912 2.0×	291 0.8×	124 0.4×	85 0.3×	73	2.9k
Siegfried Stengelin Germany	21	1.3k 1.7×	273 0.6×	813 2.3×	680 2.0×	377 1.2×	33	3.0k
Iwao Ohkubo Japan	26	874 1.2×	140 0.3×	244 0.7×	423 1.3×	108 0.3×	94	1.8k
Barbara J. Brandhuber United States	25	1.7k 2.3×	130 0.3×	1.0k 2.9×	579 1.7×	228 0.7×	37	3.0k
Sander H. Diks Netherlands	21	810 1.1×	157 0.4×	166 0.5×	191 0.6×	123 0.4×	46	1.4k
S Tsai United States	18	2.0k 2.8×	672 1.5×	819 2.3×	374 1.1×	138 0.4×	21	3.0k
Hai Le Trong United States	16	1.3k 1.7×	145 0.3×	655 1.9×	287 0.8×	93 0.3×	18	2.3k

Countries citing papers authored by Christopher L. Reading

Since Specialization

Citations

This map shows the geographic impact of Christopher L. Reading's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Reading with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Reading more than expected).

Fields of papers citing papers by Christopher L. Reading

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Reading. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Reading. The network helps show where Christopher L. Reading may publish in the future.

Co-authorship network of co-authors of Christopher L. Reading

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Reading. A scholar is included among the top collaborators of Christopher L. Reading based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Reading. Christopher L. Reading is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reading, Christopher L., Jiayan Yan, Marcia A. Testa, et al.. (2025). An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease. Frontiers in Neuroscience. 19. 1516746–1516746. 1 indexed citations

Reading, Christopher L., Clarence Ahlem, Joseph Palumbo, et al.. (2023). Metabolic dysregulation in a phase 3, placebo-controlled, randomised study of NE3107 (bezisterim) in subjects with probable Alzheimer’s disease. Neuroscience Applied. 2. 103642–103642. 1 indexed citations

Reading, Christopher L., Juozas Gordevičius, Clarence Ahlem, et al.. (2023). Treatment‐Induced Epigenetic Modifications in MCI and Probable Alzheimer’s Disease. Alzheimer s & Dementia. 19(S12). 1 indexed citations

Reading, Christopher L., James M. Frincke, & Steven K White. (2012). Molecular Targets for 17α-Ethynyl-5-Androstene-3β,7β,17β-Triol, an Anti-Inflammatory Agent Derived from the Human Metabolome. PLoS ONE. 7(2). e32147–e32147. 17 indexed citations

Kosiewicz, Michele M, Dominick L. Auci, Paolo Fagone, et al.. (2011). HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse. European Journal of Pharmacology. 658(2-3). 257–262. 9 indexed citations

Malik, Ajay K., Sophia K. Khaldoyanidi, Dominick L. Auci, et al.. (2010). 5-Androstene-3β,7β,17β-triol (β-AET) Slows Thermal Injury Induced Osteopenia in Mice: Relation to Aging and Osteoporosis. PLoS ONE. 5(10). e13566–e13566. 9 indexed citations

Auci, Dominick L., et al.. (2010). A Potential Role for 5‐Androstene‐3β,7β,17β‐triol in Obesity and Metabolic Syndrome. Obesity. 19(4). 806–811. 12 indexed citations

Ahlem, Clarence, Dominick L. Auci, Katia Mangano, et al.. (2009). HE3286: A Novel Synthetic Steroid as an Oral Treatment for Autoimmune Disease. Annals of the New York Academy of Sciences. 1173(1). 781–790. 17 indexed citations

Auci, Dominick L., Christopher L. Reading, & James M. Frincke. (2008). 7-Hydroxy androstene steroids and a novel synthetic analogue with reduced side effects as a potential agent to treat autoimmune diseases. Autoimmunity Reviews. 8(5). 369–372. 38 indexed citations

10.

Stickney, Dwight R., Armando Garsd, Clarence Ahlem, et al.. (2006). 5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression. International Immunopharmacology. 6(11). 1706–1713. 47 indexed citations

11.

Offner, Halina, Alex Zamora, Agata Matejuk, et al.. (2002). A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing–remitting EAE. Journal of Neuroimmunology. 130(1-2). 128–139. 38 indexed citations

12.

Khouri, Issa F., Michael J. Keating, H. M. Vriesendorp, et al.. (1994). Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.. Journal of Clinical Oncology. 12(4). 748–758. 146 indexed citations

13.

Deisseroth, Albert, Hagop M. Kantarjian, Moshe Talpaz, et al.. (1993). Molecular approaches to the diagnosis and treatment of cancer. Stem Cells. 11(S3). 129–130. 1 indexed citations

14.

Ellerson, Debra, Soon‐Pal Suh, David F. Claxton, et al.. (1992). Use of Cell-Free Retroviral Vector Preparations for Transduction of Cells from the Marrow of Chronic Phase and Blast Crisis Chronic Myelogenous Leukemia Patients and from Normal Individuals. Human Gene Therapy. 3(2). 137–145. 17 indexed citations

15.

Takaue, Yoichi, Tsutomu Watanabe, Yoshifumi Kawano, et al.. (1991). A simplified and rapid limiting dilution assay of T lymphocytes. Cellular Immunology. 133(2). 526–531. 2 indexed citations

16.

Seong, David, Simon H. Sims, Elizabeth Johnson, et al.. (1991). Activation of class I HLA expression by TNF‐alpha and gamma‐interferon is mediated through protein kinase C‐dependent pathway in CML cell lines. British Journal of Haematology. 78(3). 359–367. 3 indexed citations

17.

Deisseroth, A. B., C.v. Herst, Simon H. Sims, et al.. (1990). Future directions in molecular and genetic therapy for Leukemias and solid tumors. 42(3). 173–180.

18.

Reading, Christopher L., et al.. (1989). Stability of Specific Immunoglobulin Secretion by EBV-Transformed Lymphoblastoid Cells and Human-Murine Heterohybridomas. Hybridoma. 8(4). 377–389. 5 indexed citations

19.

O’Kennedy, Richard, Jenny M. Bator, & Christopher L. Reading. (1989). A microassay for the determination of iodide and its application to the measurement of the iodination of proteins and the catalytic activities of iodo compounds. Analytical Biochemistry. 179(1). 138–144. 16 indexed citations

20.

Hutchins, Jeff & Christopher L. Reading. (1988). Characterization of mono‐, di‐, and tri‐O‐acetylated sialic acids on human cells. Journal of Cellular Biochemistry. 37(1). 37–48. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact